Corbus Pharmaceuticals Holdings Inc. Stock Slips 7.7%, Underperforms Peers

Dow Jones

Feb 06

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.7% to $7.39 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 22,540.59 and Dow Jones Industrial Average falling 1.2% to 48,908.72.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 64.1% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.9% to $7.23, Fortress Biotech Inc. fell 4.9% to $2.93, and Viking Therapeutics Inc. fell 11.06% to $26.29.

Trading volume totaled 221,723, compared to the 50-day average of 307,806.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

February 05, 2026 16:35 ET (21:35 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2609024582"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609024582\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609024582?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 05:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609024582","market":"fut","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Slips 7.7%, Underperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.7% to $7.39 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 22,540.59 and Dow Jones Industrial Average falling 1.2% to 48,908.72. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 64.1% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.9% to $7.23, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> fell 4.9% to $2.93, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. fell 11.06% to $26.29. \n</p>\n<p>\n     Trading volume totaled 221,723, compared to the 50-day average of 307,806. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2026 16:35 ET (21:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Slips 7.7%, Underperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Slips 7.7%, Underperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-06 05:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.7% to $7.39 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 22,540.59 and Dow Jones Industrial Average falling 1.2% to 48,908.72. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 64.1% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.9% to $7.23, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> fell 4.9% to $2.93, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. fell 11.06% to $26.29. \n</p>\n<p>\n     Trading volume totaled 221,723, compared to the 50-day average of 307,806. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2026 16:35 ET (21:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2609024582","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609024582","pubTimestamp":1770327300,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.7% to $7.39 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 22,540.59 and Dow Jones Industrial Average falling 1.2% to 48,908.72.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 64.1% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.9% to $7.23, Fortress Biotech Inc. fell 4.9% to $2.93, and Viking Therapeutics Inc. fell 11.06% to $26.29.Trading volume totaled 221,723, compared to the 50-day average of 307,806.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"Corbus Pharmaceuticals Holdings Inc.股价下跌7.7%，表现逊于同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1.5},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.7% to $7.39 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 22,540.59 and Dow Jones Industrial Average falling 1.2% to 48,908.72. \n\n\n     This was the stock's third consecutive day of losses. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed 64.1% below its 52-week high of $20.56, which the company achieved on October 20th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.9% to $7.23, Fortress Biotech Inc. fell 4.9% to $2.93, and Viking Therapeutics Inc. fell 11.06% to $26.29. \n\n\n     Trading volume totaled 221,723, compared to the 50-day average of 307,806. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2026 16:35 ET (21:35 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}